| Johnson, Nathalie |
SYMPHONY-1, NCT04224493 / 2019-003333-42: A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma. |
|
|
| Recruiting | 3 | 612 | Europe, Canada, US, RoW | Tazemetostat, EPZ-6438, IPN60200, Placebo oral tablet, Lenalidomide, Rituximab | Epizyme, Inc. | Relapsed/Refractory Follicular Lymphoma, Follicular Lymphoma, Refractory Follicular Lymphoma | 03/26 | 03/29 | | |
|
|
|
|
|
|
|
| Completed | 2 | 131 | Canada, US | brentuximab vedotin, Adcetris; SGN-35, bendamustine, dacarbazine, nivolumab | Seagen Inc., Bristol-Myers Squibb | Hodgkin Disease, Peripheral T Cell Lymphoma | 04/23 | 09/23 | | |
|
|
|
|
|
NCT05180097: Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma |
|
|
| Recruiting | 2 | 84 | Canada, RoW | Gemcitabine, Dexamethasone, Cisplatin, Brentuximab vedotin, Pembrolizumab | Canadian Cancer Trials Group, Merck Sharp & Dohme LLC, Seagen Inc., Australasian Leukaemia and Lymphoma Group | Hodgkin Lymphoma | 06/25 | 06/26 | | |
FLEX, NCT03053193: MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles |
|
|
| Recruiting | N/A | 30000 | Europe, Canada, US, RoW | MammaPrint, BluePrint, and Full-Genome Testing, MammaPrint, BluePrint | Agendia | Breast Cancer | 04/37 | 12/37 | | |
| Coordinator, Research |
| Recruiting | 4 | 3500 | US | Zoledronic Acid 5Mg/Bag 100Ml Inj, Reclast, Placebo | California Pacific Medical Center Research Institute, National Institute on Aging (NIA), University of California, San Francisco, Duke University, University of Pittsburgh, Parkinson's Foundation | Parkinson Disease, Osteoporosis, Parkinsonism, Parkinson's Disease and Parkinsonism, Atypical Parkinsonism, Progressive Supranuclear Palsy, Multiple System Atrophy, Vascular Parkinsonism, Dementia with Lewy Bodies | 02/26 | 10/26 | | |
NCT05078827: Therapeutic Equivalence of Fluorouracil Cream, 5% Compared With Fluorouracil 5% Topical Cream of MylanPharmaceuticals Inc., U.S.A in the Treatment of Actinic Keratosis |
|
|
| Completed | 3 | 458 | US | Test Product (A): Fluorouracil Cream, 5% topical cream, Experimental, Reference Product (B): Fluorouracil 5% Topical Cream of Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., Active Comparator, Placebo Product (C): Test vehicle cream for fluorouracil 5% of Encube Ethicals Pvt. Ltd., India, Placebo Comparator | Encube Ethicals Pvt. Ltd., CBCC Global Research | Actinic Keratoses | 11/22 | 12/22 | | |
| Completed | 3 | 558 | US | ReMMi-D Digital Therapeutic | Click Therapeutics, Inc. | Migraine, Episodic Migraine, Headache, Headache, Migraine | 05/24 | 05/24 | | |
OPERA-T, NCT05238116 / 2021-004554-32: Safety and Efficacy of PC945 (Opelconazole) in Combination With Other Antifungal Therapy for the Treatment of Refractory Invasive Pulmonary Aspergillosis ( Study) |
|
|
| Recruiting | 3 | 123 | Europe, Canada, US, RoW | PC945, Placebo | Pulmocide Ltd | Refractory IPA | 03/25 | 04/25 | | |
NCT06004388: Study of Two Digital Therapeutics for the Prevention of Episodic Migraine Receiving CGRP Therapy (ReMMiD-C) |
|
|
| Active, not recruiting | 3 | 110 | US | Click Digital Therapeutic | Click Therapeutics, Inc. | Migraine, Episodic Migraine, Headache, Headache, Migraine | 05/24 | 06/24 | | |
SKOAP, NCT04504812: A Sequenced Strategy for Improving Outcomes in People With Knee Osteoarthritis Pain |
|
|
| Active, not recruiting | 3 | 1800 | US | Duloxetine, Cymbalta, Intra-Articular Injection, Nerve Procedure with long acting blocks, Nerve Procedure with nerve ablation, Pain Coping Skills Training, Best Practices | Johns Hopkins University, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Knee Osteoarthritis | 03/25 | 03/25 | | |
CONVOKE, NCT05838625: Study of Two Digital Therapeutics for the Treatment of Experiential Negative Symptoms of Schizophrenia |
|
|
| Recruiting | 3 | 432 | US | Digital Therapeutic | Click Therapeutics, Inc., Boehringer Ingelheim | Schizophrenia | 06/25 | 07/25 | | |
NCT06067984: An Extension Study of a Second Course of a Digital Therapeutic for the Treatment of Experiential Negative Symptoms of Schizophrenia |
|
|
| Recruiting | 3 | 216 | US | Study App | Click Therapeutics, Inc., Boehringer Ingelheim | Schizophrenia, Negative Symptoms in Schizophrenia | 09/24 | 10/24 | | |
| Active, not recruiting | 2/3 | 1500 | US | Zilucoplan, Verdiperstat, CNM-Au8, Pridopidine, SLS-005 Trehalose, ABBV-CLS-7262, DNL343 | Merit E. Cudkowicz, MD, Massachusetts General Hospital | Amyotrophic Lateral Sclerosis | 07/25 | 04/26 | | |
NCT06365437: A Dose Escalation Study of TCD601 Compared to ATG in de Novo Renal Transplantation |
|
|
| Active, not recruiting | 2 | 40 | Europe | TCD601, Siplizumab, Tacrolimus (TAC), Corticosteroids (CS), Mycophenolate Mofetil (MMF), ATG | ITB-Med LLC | Kidney Transplantation | 07/25 | 07/25 | | |
| Recruiting | 2 | 25 | Europe, Canada, Japan, US, RoW | nedosiran, DCR-PHXC | Dicerna Pharmaceuticals, Inc., a Novo Nordisk company | Primary Hyperoxaluria, Primary Hyperoxaluria Type 1, Primary Hyperoxaluria Type 2, Primary Hyperoxaluria Type 3 | 12/24 | 12/24 | | |
NCT03651700: Transcranial Magnetic Stimulation and Constraint Induced Language Therapy for Chronic Aphasia |
|
|
| Active, not recruiting | 2 | 83 | US | Active TMS, Sham TMS, CILT, Constraint Induced Language Therapy | H. Branch Coslett, National Institutes of Health (NIH), National Institute on Deafness and Other Communication Disorders (NIDCD) | Aphasia | 08/24 | 08/24 | | |
CHASE, NCT05727878: Trial to Evaluate Safety and Efficacy of KPI-012 Ophthalmic Solution in Participants With PCED |
|
|
| Recruiting | 2 | 90 | US, RoW | KPI-012, KPI-012 Vehicle | Combangio, Inc, Kala Pharmaceuticals, Inc. | Persistent Corneal Epithelial Defect | 03/25 | 10/25 | | |
NCT05733546: A Phase II, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of COMP360 in Participants With Recurrent Major Depressive Disorder |
|
|
| Recruiting | 2 | 102 | US | Psilocybin, COMP360 | COMPASS Pathways | Major Depressive Disorder | 10/24 | 11/24 | | |
NCT04270175: Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Previously Exposed to Daratumumab |
|
|
| Recruiting | 2 | 21 | US | Daratumumab SC, Faspro, Pomalidomide, Dexamethasone | Weill Medical College of Cornell University, Janssen Scientific Affairs, LLC | Amyloid, AL Amyloidosis, Refractory AL Amyloidosis | 12/25 | 12/29 | | |
NCT04803058: A Study of TCD601 in the Induction of Tolerance in Renal Transplantation (PERSPECTIVE) |
|
|
| Recruiting | 2 | 18 | US, RoW | TCD601 | ITB-Med LLC | Kidney Transplantation | 03/27 | 03/30 | | |
| Not yet recruiting | 2 | 20 | US | Sodium Thiosulfate (STS) | Robyn T. Domsic, MD, MPH, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Systemic Sclerosis (SSc), Dermatomyositis, Mixed Connective Tissue Disease (MCTD), Calcinosis | 05/25 | 11/25 | | |
| Active, not recruiting | 2 | 96 | Europe | TCD601, Placebo | ITB-Med LLC | Diabetes Mellitus, Type 1 | 01/25 | 01/25 | | |
| Recruiting | 2 | 90 | US | TCD601, siplizumab, belatacept, ATG, antithymocyte globulin, TAC, tacrolimus, MPA, mycophenolic acid, Corticosteroids | ITB-Med LLC | Renal Transplantation | 07/25 | 10/26 | | |
NCT04311632: A Dose Escalation Study in de Novo Renal Transplantation |
|
|
| Completed | 2 | 13 | US | TCD601, Tacrolimus (TAC), Corticosteroids (CS), Mycophenolate Mofetil (MMF), ATG | ITB-Med LLC | Kidney Transplantation | 10/23 | 10/23 | | |
NCT04464980: Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD) |
|
|
| Recruiting | 2 | 2190 | US | SL-BUP, sublingual buprenorphine, Suboxone, XR-BUP, extended-release buprenorphine, CAM2038, Brixadi, XR-NTX, extended-release naltrexone, Vivitrol, MM, MMR, MMD | NYU Langone Health, New York State Psychiatric Institute, Columbia University, Harvard Medical School (HMS and HSDM), Mclean Hospital, National Institute on Drug Abuse (NIDA), The Emmes Company, LLC | Opioid Use Disorder (OUD) | 07/26 | 12/26 | | |
NCT04803006: A Study of TCD601 in the Induction of Tolerance in Renal Transplantation (PANORAMA) |
|
|
| Recruiting | 2 | 18 | US | TCD601 | ITB-Med LLC | Kidney Transplantation | 07/27 | 07/30 | | |
NCT04892251: Ketamine Assisted Psychotherapy for Opioid Use Disorder |
|
|
| Recruiting | 1/2 | 60 | US | MORE+KAP, MORE | University of Utah | Opioid-use Disorder | 12/23 | 05/24 | | |
NCT04482179: Transcranial Magnetic Stimulation and Constraint Induced Language Therapy for Alzheimer Disease |
|
|
| Active, not recruiting | 1 | 30 | US | Active TMS, CILT, Constraint Induced Language Therapy, Sham TMS | University of Pennsylvania, National Institutes of Health (NIH), National Institute on Deafness and Other Communication Disorders (NIDCD) | Alzheimer Disease | 08/24 | 08/24 | | |
AURORA, NCT06453668: A Study of TCD601 (Siplizumab) in Newly Diagnosed Adult Amyotrophic Lateral Sclerosis (ALS) Patients |
|
|
| Active, not recruiting | 1 | 48 | Europe | TCD601, siplizumab | ITB-Med LLC | ALS | 11/26 | 11/26 | | |
| Recruiting | 1 | 15 | US | PBA-0405, PB004.22.0405.aF | Pure Biologics S.A., Presage Biosciences | Head and Neck Squamous Cell Carcinoma, Soft Tissue Sarcoma Adult, Triple Negative Breast Cancer | 03/25 | 03/25 | | |
MST01-AZN-05, NCT06366451: PBI-MST-01 (NCT04541108) Substudy AZN-05: Intratumoral Microdosing of Rilvegostomig, Volrustomig, and Sabestomig in HNSCC |
|
|
| Recruiting | 1 | 15 | US | Rilvegostomig, AZD2936, Volrustomig, MEDI5752, Sabestomig, AZD7789, Pembrolizumab, Keytruda, MK-3475 | Presage Biosciences, AstraZeneca | Head and Neck Squamous Cell Carcinoma | 12/24 | 03/25 | | |
NCT05508906: Phase 1b Combo w/ Ribociclib, Alpelisib, or Everolimus |
|
|
| Recruiting | 1 | 155 | US, RoW | OP-1250, Ribociclib, KISQALI®, Alpelisib, PIQRAY®, Everolimus | Olema Pharmaceuticals, Inc., Novartis | Metastatic Breast Cancer, Advanced Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer, Breast Cancer | 05/26 | 06/26 | | |
NCT04541108: Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies |
|
|
| Recruiting | 1 | 15 | US | Rilvegostomig, AZD2936, Volrustomig, MEDI5752, Sabestomig, AZD7789, Pembrolizumab, Keytruda, MK-3475 | Presage Biosciences, Merck Sharp & Dohme LLC | Solid Tumor | 12/31 | 12/31 | | |
NCT06129084: A Study to Compare the Results of FGFR Testing by Either CtDNA Blood Testing or Standard Tumor Tissue Testing |
|
|
| Recruiting | N/A | 260 | Canada | FGFR Testing | Bernie Eigl, Vancouver Prostate Centre, Lady Davis Institute, Bladder Cancer Canada | Metastatic Bladder Cancer, Metastatic Urothelial Carcinoma | 03/25 | 05/25 | | |
| Completed | N/A | 190 | US | Cigarette flavor type | University of Oklahoma | Smoking, Cigarette | 12/22 | 01/23 | | |
NCT03869463: Computerized Cognitive Training in Young Adults With Depression |
|
|
| Terminated | N/A | 28 | US | Computerized Cognitive Training, Control | Queens College, The City University of New York | Depressive Symptoms | 03/23 | 03/23 | | |
NCT03495011: MRI Characterization of Mammographically Detected DCIS |
|
|
| Active, not recruiting | N/A | 122 | US | Breast MRI, Laboratory Biomarker Analysis, Oncotype Dx | University of Washington, National Cancer Institute (NCI), National Institutes of Health (NIH) | Breast Cancer, Stage 0 | 04/23 | 04/32 | | |
| Recruiting | N/A | 35 | US | MRI, blood draw, Clinical assessments | University of Vermont, National Institute of General Medical Sciences (NIGMS) | Stroke, Acute, Gait, Hemiplegic | 05/23 | 05/23 | | |
NCT04902339: Near-infrared Spectroscopy-based Neurofeedback as Adjunct to Mindfulness-Oriented Recovery Enhancement in Persons With Chronic Pain |
|
|
| Recruiting | N/A | 75 | US | Mindfulness-Oriented Recovery Enhancement, Neurofeedback, Supportive Psychotherapy | University of Utah | Chronic Pain Syndrome, Opioid Use | 05/23 | 08/23 | | |
NCT04088773: Biomarkers of Intestinal Fibrosis in Small Bowel Crohn's Disease |
|
|
| Active, not recruiting | N/A | 232 | US | blood biomarkers, stool biomarkers, MRI imaging | Children's Hospital Medical Center, Cincinnati, The Leona M. and Harry B. Helmsley Charitable Trust | Crohn Disease | 09/23 | 09/24 | | |
NCT06136936: A Study to Evaluate the Overall Effects of Treatment With Abbreviated CT-156 in People With Schizophrenia |
|
|
| Completed | N/A | 53 | US | CT-156-C-001 | Click Therapeutics, Inc., Boehringer Ingelheim | Schizophrenia | 01/24 | 02/24 | | |
| Recruiting | N/A | 20 | US | Prototypes of breast shield and Freedom Double Electric Breast Pump | Momtech Inc. | Healthy, Breast Pumping | 09/24 | 11/24 | | |
NCT06136923: An Exploratory Study to Evaluate Attention Biases in Adults With Multiple Sclerosis, Breast Cancer, and Lung Cancer |
|
|
| Completed | N/A | 194 | US | CT-100-D-004-A, CT-100-D-004-B | Click Therapeutics, Inc. | Multiple Sclerosis, Lung Cancer, Breast Cancer | 04/24 | 05/24 | | |
NCT05465395: Upper Cervical and Thoracic Chiropractic Adjustment |
|
|
| Suspended | N/A | 40 | US | Upper Cervical Adjustemnt, Thoracic Adjustemnt | Life University | Stress | 11/23 | 11/23 | | |
| Completed | N/A | 314 | US | FemaSeed Localized Directional Insemination | Femasys Inc. | Infertility, Male Factor | 12/23 | 04/24 | | |
CT-100-D-003, NCT06275659: An Exploratory Study to Evaluate a Digital Intervention to Disrupt Scratching in Atopic Dermatitis and Psoriasis |
|
|
| Active, not recruiting | N/A | 120 | US | CT-100-004-A, CT-100-004-B | Click Therapeutics, Inc. | Psoriasis, Atopic Dermatitis | 02/24 | 03/24 | | |
NCT05617300: Mindfulness-based Dementia Care Partner Program to Reduce Depressive Symptoms |
|
|
| Completed | N/A | 130 | US | Mindfulness-Based Dementia Caregiving | HealthPartners Institute | Dementia | 12/23 | 03/24 | | |
NCT04685044: Testing a 32-channel Transmit/Receive MRI Head Array |
|
|
| Active, not recruiting | N/A | 15 | Canada | IH 1Tx32Rx Head Array | Lawson Health Research Institute | Magnetic Resonance Imaging | 12/23 | 12/23 | | |
| Completed | N/A | 172 | US | Very low nicotine cigarettes | University of Oklahoma | Cigarette Smoking, Smoking Behaviors | 03/24 | 04/24 | | |
NCT03303248: Evaluation of Web-based Transition Education to Enhance Transition Readiness |
|
|
| Active, not recruiting | N/A | 180 | US | Web-based Educational Intervention | University of Michigan, University of Nebraska | Congenital Heart Disease, Transition, Pediatric Congenital Heart Disease | 12/24 | 12/24 | | |
| Completed | N/A | 60 | US | alcohol beverage, Placebo beverage | University of Texas at Austin | Bipolar Disorder, Alcohol Drinking, Alcohol Use Disorder | 03/24 | 03/24 | | |
NCT04625959: Optimizing Mindfulness and Acceptance Based Behavioral Treatment for Bulimia Nervosa and Binge Eating Disorder |
|
|
| Active, not recruiting | N/A | 256 | US | Behavioral Therapy for Eating Disorders, MABT: Mindful Awareness, MABT: Values, MABT: Emotion Modulation, MABT: Distress Tolerance | Drexel University, National Institute of Mental Health (NIMH) | Bulimia Nervosa, Bulimia; Atypical, Binge-Eating Disorder, Binge-Eating and Purging Type Anorexia Nervosa, Binge Eating | 04/24 | 04/24 | | |
NCT06330246: O. Formigenes Colonization in Calcium Oxalate Kidney Stone Disease |
|
|
| Recruiting | N/A | 40 | US | Low oxalate fixed diets pre-colonization, Moderately high oxalate fixed diets pre-colonization, Colonization with Oxalobacter formigenes, Low oxalate fixed diets post-colonization, Moderately high oxalate fixed diets post-colonization | University of Alabama at Birmingham, University of Texas Southwestern Medical Center, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Kidney Stone, Kidney Calculi, Urolithiasis, Urolithiasis, Calcium Oxalate, Nephrolithiasis, Nephrolithiasis, Calcium Oxalate, Oxalate Urolithiasis, Oxaluria | 12/30 | 12/31 | | |
NCT06331546: Gut Oxalate Absorption in Calcium Oxalate Stone Disease |
|
|
| Recruiting | N/A | 80 | US | Low-oxalate diet, High-oxalate diet, soluble oxalate gut absorption test | University of Alabama at Birmingham, University of Texas Southwestern Medical Center, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Kidney Stone, Kidney Calculi, Urolithiasis, Urolithiasis, Calcium Oxalate, Nephrolithiasis, Nephrolithiasis, Calcium Oxalate, Oxalate Urolithiasis, Oxaluria, Healthy | 12/30 | 12/31 | | |
SWAT, NCT06588101: Clinical Trial Recruitment and Retention Strategies for Family Members in the ICU |
|
|
| Recruiting | N/A | 160 | Canada | Written informed consent with infographic, Compensation | Lady Davis Institute, Canadian Institutes of Health Research (CIHR) | Family Members, Recruitment, Clinical Study, Retention, Recruitment of Participants, Study Enrollment, Retention of Participants, Compensation Incentives | 04/25 | 12/25 | | |
NCT06431386: Behavioural Activation Therapy and Esketamine for Resistant Depression |
|
|
| Recruiting | N/A | 40 | Canada | Behavioural Activation (BA) Therapy, Esketamine | The Royal's Institute of Mental Health Research | Depressive Disorder, Treatment-Resistant, Depressive Disorder, Major, Bipolar Disorder | 08/26 | 08/26 | | |
| Completed | N/A | 68 | US | Alcohol beverage, Placebo beverage | University of Texas at Austin | Bipolar Disorder, Alcohol Drinking, Alcohol Use Disorder | 06/24 | 06/24 | | |
NCT04279483: GeoScan and Remote Geo Smoking Study: Neural and Behavioral Correlates of Smokers' Exposure to Retail Environments |
|
|
| Completed | N/A | 336 | US | 7-11, CVS | Abramson Cancer Center at Penn Medicine, National Cancer Institute (NCI), New York University, Stanford University | Smoking, Tobacco, Smoking, Smoking, Cigarette | 06/24 | 06/24 | | |
NCT05884437: The Effects of Chiropractic in Adults With Metabolic Syndrome |
|
|
| Suspended | N/A | 10 | US | Chiropractic adjustment | Life University | Metabolic Syndrome | 07/25 | 12/25 | | |
I-YMSC, NCT06657950: Treatments for Improving Mood in Women Survivors of Interpersonal Violence: A Community-Engaged Study-1.2 |
|
|
| Recruiting | N/A | 15 | US | Integrative hatha yoga and mindful self-compassion | Butler Hospital, National Center for Complementary and Integrative Health (NCCIH) | Distress | 09/25 | 09/25 | | |
NCT06385392: Continuous Wearable Monitor for the Detection and Release of Freezing of Gait. |
|
|
| Recruiting | N/A | 36 | US | Haptic module and insole device | HealthPartners Institute | Parkinson Disease | 05/25 | 05/25 | | |
Lublin, NCT06217081: 3M™ Topical Tissue Adhesive Versus Commercially Available Tissue Adhesive for the Closure of Lacerations and Incisions |
|
|
| Recruiting | N/A | 452 | US | 3M Topical Tissue Adhesive, Histoacryl® Blue Topical Skin Adhesive | Solventum US LLC, United States Department of Defense, The University of Texas Health Science Center at San Antonio, 3M | Trauma-related Wound, Surgical Incision, Surgical Wound, Laceration | 08/25 | 09/25 | | |
NCT06172660: Real-World Effectiveness of Perinatal RSV Immunoprophylaxis |
|
|
| Recruiting | N/A | 3750 | US | Nirsevimab, RSV vaccines | Yale University, National Institute of Allergy and Infectious Diseases (NIAID) | RSV Infection | 12/28 | 12/28 | | |
| Recruiting | N/A | 750 | Canada | Cardiac monitoring device | Population Health Research Institute | Atrial Fibrillation, Atrial Flutter | 08/26 | 12/26 | | |
NCT03556683: Phase I Assessment of Hypertonic Saline in Moderate to Severe Asthmatics |
|
|
| Completed | N/A | 22 | US | 3% Hypertonic Saline, 7% Hypertonic Saline | University of North Carolina, Chapel Hill, National Heart, Lung, and Blood Institute (NHLBI) | Moderate to Severe Asthma | 06/24 | 06/24 | | |
| Recruiting | N/A | 50 | US | Pulmonary Valve Replacement Surgery | Autus Valve Technologies, Inc. | Congenital Heart Disease | 08/26 | 02/36 | | |
| Recruiting | N/A | 800 | US | Myriad Matrix™ and Myriad Morcells™ | Aroa Biosurgery Limited | Abdominal Wound Dehiscence, Necrotizing Soft Tissue Infection, Lower Extremity Wound, Pilonidal Sinus, Anal Fistula, Hidradenitis Suppurativa, Pressure Injury | 01/28 | 01/29 | | |
| Recruiting | N/A | 900 | Canada | A-EAAA Sexual Assault Resistance Education Program immediately, Girls -- Flip the Script with EAAA, Usual care + A-EAAA at 6 months | University of Windsor, Public Health Agency of Canada (PHAC) | Sexual Assault | 12/25 | 12/25 | | |
| Not yet recruiting | N/A | 100 | US | Surveys and Interviews - Arm A, COPD Care Pathway | Wake Forest University Health Sciences, National Cancer Institute (NCI) | Chronic Obstructive Pulmonary Disease, Lung Cancer, Head and Neck Cancer | 08/25 | 08/25 | | |
NCT05893927: Impact of a Diabetes Education Mobile Web Application on Patients With Uncontrolled Type 2 Diabetes |
|
|
| Recruiting | N/A | 120 | US | Diabetes education web site application | The Reading Hospital and Medical Center, Reading Hospital Foundation, Complete Statistical Services (Consult-Stat) | Diabetes Mellitus, Type 2, Diabetes Education, Lifestyle Modification | 09/25 | 09/25 | | |
| Recruiting | N/A | 100 | US | Checkpoint BEST System, Brief Electrical Stimulation (BES) Therapy | Checkpoint Surgical Inc., Congressionally Directed Medical Research Programs | Cubital Tunnel Syndrome, Nerve Compression, Nerve Injury, Ulnar Neuropathies | 12/25 | 12/25 | | |
NCT05473013: Optimizing Digital Health Technology Interventions to Increase Skill Acquisition and Utilization |
|
|
| Recruiting | N/A | 264 | US | Behavioral Therapy for Eating Disorders, Skills Monitoring On, Enhanced Skills Monitoring, Automated Reminder Messages, Micro-Intervention 1, JITAIs, Micro-Intervention 2 | Drexel University, National Institute of Mental Health (NIMH) | Bulimia Nervosa, Bulimia, Binge Eating, Binge-Eating Disorder | 12/25 | 03/26 | | |
| Recruiting | N/A | 573 | US | FemBloc | Femasys Inc. | Contraception | 12/29 | 06/31 | | |
MIMIC2, NCT05702021: Implementing Contingency Management for Stimulant Use in Specialty Addiction Treatment Organizations |
|
|
| Not yet recruiting | N/A | 76 | NA | Science to Service Laboratory | Northwestern University, National Institute on Drug Abuse (NIDA), Stanford University, Ohio State University | Stimulant Use (Diagnosis) | 04/27 | 08/27 | | |
NCT05445180: Investigating the Neural Correlates of Cognitive Function in Psychosis Patients and Non-Psychiatric Controls With Cannabis Use |
|
|
| Recruiting | N/A | 134 | Canada | Contingency management | Douglas Mental Health University Institute | Psychotic Disorders, Cannabis Use Disorder, Cannabis Dependence, Cannabis Use, Schizophrenia; Psychosis, Cognitive Dysfunction, Memory Impairment, Neuroimaging | 05/27 | 05/27 | | |
| Recruiting | N/A | 60 | US | Checkpoint BEST System, Brief Electrical Stimulation (BES) Therapy | Checkpoint Surgical Inc., Congressionally Directed Medical Research Programs | Nerve Injury, Peripheral Nerve Injuries, Peripheral Nerve Injury Upper Limb, Nerve Palsy | 06/27 | 06/27 | | |
NCT05678634: Optimizing Feedback-based Learning in Children With Developmental Language Disorder |
|
|
| Recruiting | N/A | 140 | US | Declarative learning with immediate feedback, Declarative learning with delayed feedback, Probabilistic learning with immediate feedback, Probabilistic learning with delayed feedback, Word learning task with active feedback, Word learning task with passive feedback | MGH Institute of Health Professions | Developmental Language Disorder | 10/27 | 10/27 | | |
Long_BACS, NCT05838274: Acute Alcohol Response In Bipolar Disorder: a Longitudinal Alcohol Administration/fMRI Study |
|
|
| Recruiting | N/A | 100 | US | Alcohol vs. Placebo beverage conditions | University of Texas at Austin | Bipolar Disorder, Alcohol Drinking, Alcohol Use Disorder | 03/28 | 03/28 | | |
| Recruiting | N/A | 200 | US | Alcohol, Placebo | University of Texas at Austin | Post-Traumatic Stress Disorder, Alcohol Drinking | 05/28 | 05/28 | | |
| Recruiting | N/A | 60 | US | Low-oxalate controlled diet, Primed, continuous intravenous infusion of 13C2-oxalate | University of Alabama at Birmingham | Healthy, Kidney Stone, Obesity | 10/29 | 10/30 | | |
NCT05678530: Observational, Non-Interventional Study Supporting Validation of VO2Max Estimation Methods Using Results in Patients Receiving Standard of Care Cardiopulmonary Exercise Tests (CPET) |
|
|
| Recruiting | N/A | 400 | Canada, US | | Prolaio | Cardiopulmonary | 06/25 | 06/25 | | |
| McConnell, Lisa |
FLEX, NCT03053193: MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles |
|
|
| Recruiting | N/A | 30000 | Europe, Canada, US, RoW | MammaPrint, BluePrint, and Full-Genome Testing, MammaPrint, BluePrint | Agendia | Breast Cancer | 04/37 | 12/37 | | |
| Callahan, Michael J |
ENGOT-EN20, NCT05611931: Selinexor in Maintenance Therapy After Systemic Therapy for Participants with P53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma |
|
|
| Recruiting | 3 | 220 | Europe, Canada, US, RoW | Selinexor, KPT-330, Matching Placebo for selinexor | Karyopharm Therapeutics Inc, GOG Foundation, European Network of Gynaecological Oncological Trial Groups (ENGOT), Belgium and Luxembourg Gynaecological Oncology Group, North Eastern German Society of Gynaecological Oncology, Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies, Spanish Research Group in Ovarian Cancer, The Central and Eastern European Gynecologic Oncology Group, Israeli Society of Gynecologic Oncology, Australia New Zealand Gynaecological Oncology Group | Endometrial Cancer | 01/25 | 01/28 | | |
|
NRG-GY019, NCT04095364: Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer |
|
|
| Recruiting | 3 | 450 | Europe, Canada, US, RoW | Biopsy, BIOPSY_TYPE, Bx, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Carboplatin, Blastocarb, Carboplat, Carboplatin Hexal, Carboplatino, Carboplatinum, Carbosin, Carbosol, Carbotec, CBDCA, Displata, Ercar, JM-8, JM8, Nealorin, Novoplatinum, Paraplatin, Paraplatin AQ, Paraplatine, Platinwas, Ribocarbo, Imaging Technique, Diagnostic Imaging Technique, Image Type, Imaging, Imaging (procedure), imaging procedure, Imaging Procedures, imaging type, IMAGING_METHOD, imaging_type, Medical Imaging, Type of imaging, Letrozole, CGS 20267, Femara, Fempro, Paclitaxel, Anzatax, Asotax, Bristaxol, Praxel, Taxol, Taxol Konzentrat | NRG Oncology, National Cancer Institute (NCI) | Low Grade Fallopian Tube Serous Adenocarcinoma, Ovarian Low Grade Serous Adenocarcinoma, Primary Peritoneal Low Grade Serous Adenocarcinoma, Stage II Fallopian Tube Cancer AJCC v8, Stage II Ovarian Cancer AJCC v8, Stage II Primary Peritoneal Cancer AJCC v8, Stage III Fallopian Tube Cancer AJCC v8, Stage III Ovarian Cancer AJCC v8, Stage III Primary Peritoneal Cancer AJCC v8, Stage IV Fallopian Tube Cancer AJCC v8, Stage IV Ovarian Cancer AJCC v8, Stage IV Primary Peritoneal Cancer AJCC v8 | 02/27 | 02/28 | | |
GLORIOSA, NCT05445778: Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Ovarian, Fallopian Tube, or Peritoneal Cancer |
|
|
| Recruiting | 3 | 418 | Europe, Canada, US, RoW | Mirvetuximab soravtansine plus Bevacizumab, MIRV, Bevacizumab | ImmunoGen, Inc., GOG Foundation | Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer | 03/27 | 04/29 | | |
| Active, not recruiting | 2 | 51 | US | Ribociclib, Letrozole | Gynecologic Oncology Group, Novartis | Low Grade Serous Carcinoma | 12/23 | 12/24 | | |
NCI-2017-01672, NCT03660826: Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone |
|
|
| Active, not recruiting | 2 | 288 | Canada, US | Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Bone Marrow Aspirate, BONE MARROW, LIQUID, Human Bone Marrow Aspirate, Bone Marrow Biopsy, Biopsy of Bone Marrow, Biopsy, Bone Marrow, Capivasertib, AZD 5363, AZD-5363, AZD5363, Truqap, Cediranib, AZ-D2171, AZD 2171, AZD2171, Cediranib Maleate, AZD2171 Maleate, Recentin, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Durvalumab, Imfinzi, Immunoglobulin G1, Anti-(Human Protein B7-H1) (Human Monoclonal MEDI4736 Heavy Chain), Disulfide with Human Monoclonal MEDI4736 Kappa-chain, Dimer, MEDI 4736, MEDI-4736, MEDI4736, Echocardiography, EC, Multigated Acquisition Scan, Blood Pool Scan, Equilibrium Radionuclide Angiography, Gated Blood Pool Imaging, Gated Heart Pool Scan, MUGA, MUGA Scan, Multi-Gated Acquisition Scan, Radionuclide Ventriculogram Scan, Radionuclide Ventriculography, RNV Scan, RNVG, SYMA Scanning, Synchronized Multigated Acquisition Scanning, Olaparib, AZD 2281, AZD-2281, AZD2281, KU 0059436, KU-0059436, KU0059436, Lynparza, Olanib, Olaparix, PARP Inhibitor AZD2281 | National Cancer Institute (NCI), NRG Oncology | Endometrial Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Endometrial Undifferentiated Carcinoma, Endometrioid Adenocarcinoma, Stage IV Uterine Corpus Cancer AJCC v8 | 12/24 | 12/24 | | |
| Recruiting | 2 | 51 | US | Alpelisib Pill, Piqray, Fulvestrant injection, Faslodex | GOG Foundation, Novartis | Endometroid Endometrial Cancer | 04/25 | 04/26 | | |
